Paul Ziegler Appointed President and CEO of Augmedics

Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced Paul Ziegler as President and Chief Executive Officer. With the appointment, Gwen Watanabe will transition from interim CEO and serve as Vice Chair of the Board.

Paul Ziegler, a 20-year medical device veteran, joins Augmedics with a proven track record in commercial and operational disciplines while scaling high-growth companies. He assumes leadership as the company enters a new phase of commercial growth; in November Augmedics announced a new milestone of 100 patients treated in a single week as well as FDA clearance for a new CT-Fluoro registration method for the xvision Spine System® that greatly expands navigation access for spine surgeons.

“I am thrilled to join the Augmedics team and build on the foundation they’ve established as the leading spine-based AR platform on the market,” said Paul Ziegler. “I am excited and honored to lead the company through this next phase of growth as we capitalize on the game-changing potential of xvision to make spine surgery safer, simpler, and more reproducible.”

“We thank Gwen for her outstanding leadership during what is shaping up to be a terrific year,” said Augmedics Chairman of the Board Rick Anderson. “In Paul, we’ve found a dynamic leader with incredible energy and all the qualities needed to take Augmedics to the next level as we continue to advance our world-class AR surgical navigation offerings.”

SourceAugmedics

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”